Rankings

Market Cap
Revenue
Operating Income
CapEx
Total Assets
Net Assets
Cash on Hand

Sectors

Technology
Healthcare
Financial Services
Consumer Cyclical
Communication Services
Industrials
Consumer Defensive
Energy
Basic Materials
Real Estate
Utilities

Pages

Home
Earnings Calendar
All Sectors
Terms
Privacy

© 2026 Market Cap Arena. All rights reserved.v1.2.29

CCCC FY 2018 Earnings — C4 Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

CCCCC4 Therapeutics, Inc.

$239M

FY 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$19M

Gross Profit

-$9M-47.7% margin

Operating Income

-$16M-84.6% margin

Net Income

-$16M-81.1% margin

EPS (Diluted)

$-1.06

Cash Flow

Operating Cash Flow

-$17M

Free Cash Flow

-$20M

Stock-Based Comp.

$582,000

Balance Sheet

Total Assets

$146M

Total Liabilities

$226M

Stockholders' Equity

-$80M

Cash & Equivalents

$36M

← Q1 2019 All Quarters